Dr. Matthew Michelson serves as the CEO of Readout AI, a company at the forefront of transforming in-vivo and clinical trial data analysis. With a Ph.D. background, he brings a wealth of experience to lead the charge in reducing the time and cost associated with data interpretation. Readout AI's innovative platform empowers users to effortlessly analyze trial data, automating statistical analysis ...